Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$13.42 - $23.38 $53 - $93
-4 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$12.78 - $23.74 $51 - $94
4 New
4 $0
Q1 2020

May 15, 2020

SELL
$9.31 - $21.24 $23,135 - $52,781
-2,485 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$13.91 - $21.48 $11,809 - $18,236
-849 Reduced 25.46%
2,485 $50,000
Q3 2019

Oct 17, 2019

BUY
$15.84 - $30.01 $50,482 - $95,641
3,187 Added 2168.03%
3,334 $53,000
Q2 2019

Aug 05, 2019

SELL
$17.38 - $26.88 $5,422 - $8,386
-312 Reduced 67.97%
147 $4,000
Q4 2018

Jan 17, 2019

BUY
$9.61 - $14.02 $2,575 - $3,757
268 Added 140.31%
459 $4,000
Q3 2018

Nov 02, 2018

BUY
$8.1 - $13.6 $1,547 - $2,597
191 New
191 $0

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $283M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.